StockData
Oscar Health, Inc. logo

Oscar Health, Inc. (OSCR) stock

OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$27.57−2.27 (-7.61%)

Close on Nov 18, 2026Market cap $8.51BP/E 19.7Yield –

Oscar Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Oscar Health's revenue for the twelve months ending Jun 30, 2026 was $15.32B, up 42.8% year over year. For fiscal 2025 it was $11.70B, up 27.5% from the year before. The highest annual figure on record is $11.70B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.70B+27.5%
FY2024Dec 31, 2024$9.18B+56.5%
FY2023Dec 31, 2023$5.86B+47.9%
FY2022Dec 31, 2022$3.96B+115.6%
FY2021Dec 31, 2021$1.84B+297.3%
FY2020Dec 31, 2020$462.80M-5.2%
FY2019Dec 31, 2019$488.19M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.88B+70.4%
Q1 FY2026Mar 31, 2026$4.65B+52.6%
Q4 FY2025Dec 31, 2025$2.81B+17.3%
Q3 FY2025Sep 30, 2025$2.99B+23.2%
Q2 FY2025Jun 30, 2025$2.86B+29.0%
Q1 FY2025Mar 31, 2025$3.05B+42.2%
Q4 FY2024Dec 31, 2024$2.39B+67.1%
Q3 FY2024Sep 30, 2024$2.42B+68.3%
Q2 FY2024Jun 30, 2024$2.22B+45.9%
Q1 FY2024Mar 31, 2024$2.14B+45.8%
Q4 FY2023Dec 31, 2023$1.43B+43.9%
Q3 FY2023Sep 30, 2023$1.44B+47.2%
Q2 FY2023Jun 30, 2023$1.52B+49.6%
Q1 FY2023Mar 31, 2023$1.47B+51.1%
Q4 FY2022Dec 31, 2022$995.13M+100.6%
Q3 FY2022Sep 30, 2022$978.43M+120.4%
Q2 FY2022Jun 30, 2022$1.02B+92.2%
Q1 FY2022Mar 31, 2022$972.77M+163.3%
Q4 FY2021Dec 31, 2021$496.07M+214.6%
Q3 FY2021Sep 30, 2021$443.98M+336.6%
Q2 FY2021Jun 30, 2021$529.28M+358.9%
Q1 FY2021Mar 31, 2021$369.39M+319.3%
Q4 FY2020Dec 31, 2020$157.67M–
Q3 FY2020Sep 30, 2020$101.70M–
Q2 FY2020Jun 30, 2020$115.33M–
Q1 FY2020Mar 31, 2020$88.10M–

More Oscar Health figures

See a number that looks wrong?